Join Oxford Nanopore Technologies and the Atlantic Cancer Research Institute for the official launch of their Nanopore sequencing offering and the Discovery Program pilot project.

Attendees will have the opportunity to learn more about the comprehensive sequencing solutions offered by Oxford Nanopore Technologies (ONT) at the Atlantic Cancer Research Institute (ACRI). The session will also feature insights from Dr. John Archibald, Professor in the Department of Biochemistry and Molecular Biology and the Department of Microbiology and Immunology at Dalhousie University. Dr. Archibald will share how partnering with ONT enabled him to maximize the impact of his sequencing projects and advance his research.
Lunch and donuts will be provided for registered participants.